Thematic products have become a critical part of the investing landscape by providing investors focused exposure to a sector or a group of companies in order to capitalize on a specific and timely trend. This month’s Thematic Times focuses on the biotechnology sector, where innovation and acquisition potential provide ample room for price movement. However, uncertainty within the sector makes indexed strategies a simpler and more suitable solution than stock picking for many investors.

Read here

Other posts

Thoughts From The Divide: Signals vs Omens – Sept 6

BY JON WEBB
Call me superstitious, but some irrational part of me can’t help but think the disappointment surrounding the Nvidia results had wider significance. Like  Mary Poppins leaving when the wind changes, sometimes it’s something mundane which, with the benefit of hindsight, signals a shift in sentiment. It’s not that Nvidia never disappoints, but it has come to feel like that recently. And since the Nvidia results, stocks do seem to have lost their mojo, in marked contrast to bonds. Read more →

Trump Pushes Off EU Tariff Deadline, Lifting Equity Futures, But…

BY TEMATICA
Nvidia earnings, April PCE Data, investor conferences ahead Read more →

NDR Dynamic Allocation Strategy June 2023 Update

BY BRIAN SANBORN
Dynamic Allocation Strategy, indicators, weightings update Read more →
Back to all posts →